Juvenile Parkinsonism has been recognised for many years. Willige,' Mjones,2 Ota et al, 3 Martin,4 Carlier and Dubru,5 described several cases of juvenile Parkinsonism and did not find essential differences from classical Parkinson's disease apart from the frequent occurrence of familial cases1 2 45 or consanguineous marriage of the parents. 3 In 1981 Yokochi and Narabayashi6 defined juvenile Parkinsonism by its idiopathic character and its onset before the age of40 years. They considered the clinical picture, evolution and pharmacological features of juvenile Parkinsonism different from classical Parkinson's disease. They subdivided their 40 cases, which represented 10-6% of their Parkinsonian population into three groups. The mean age ofonset ofthe disease was rather younger in the third group (6-16 years) , than in the other two years in the first group and 16-38 in the second group). In all groups rigidity and akinesia were the main symptoms, whilst tremor was less marked. Dystonia of the foot was the usual first symptom in the third group. Mental and autonomic disturbances were rare. The evolution of the disease was slower than in classical Parkinson's disease. Immediate and marked therapeutic response to levodopa was characteristic of the first and third groups. Severe dyskinesia, choreic or ballistic, occurred in nine out of 10 The average age of onset of idiopathic Parkinson's disease is 55-3 years, starting between the age of 50 and 60 in two thirds of the cases.2' Onset of the disease before the age of 40 has been reported in between 9-4% and 18.4%6 7 of hospital based series, but is very rare in the general Parkinsonian population.
Parkinsonism beginning at such an early age raises diagnostic problems. None of our patients had a Kayser-Fleischer ring, hepatic disorder nor a low serum coeruloplasmin or copper,22 thus excluding Wilson's disease. 23 24 The juvenile form of Hunt- ington's disease25 26 was also ruled out by the absence of an antecedent familial history in all cases, dementia during the course of the disease and also the absence of caudate nucleus atrophy in the CT scan. The olivoponto-cerebellar atrophies°1' and striatonigral degeneration'12 27 28 can develop or begin with extrapyramidal symptoms of Parkinsonism. The long evolution of our cases, the absence of other neurological signs, their good response to levodopa and the CT scan findings, constitute grounds for considering any of these diagnostic possibilities unlikely. The differential diagnosis of juvenile Parkinsonism is further complicated by the neuropathological and biochemical analysis of some cases which have suggested the existence of several morphological29-31 and biochemical syndromes.432 In none of our patients were pathological studies carried out. Nevertheless in spite of the metabolic investigations the aetiology of Parkinson's disease in these subjects continues to be unknown and remains idiopathic.
The 21 patients of our series fulfil the criteria for a clinical diagnosis of idiopathic Parkinson's disease. 2' In two patients the CT scan showed coexistent cerebral infarction. These patients are now in their 70s and have had a long evolution of Parkinsonism. Cerebral infarction was clinically detected in one of these patients, and by CT scan in the other who had severe arterial hypertension. A third patient had bilateral calcification of the pallidum. Basal ganglia calcification, especially involving the pallidum33 4 has been observed in patients with diverse symptomatology not attributable to the calcification and is not regarded as a nosological entity. Although Parkinsonism associated with basal ganglia calcification has been said to be resistant to levodopa treatment,35 our patient (who had normal calcium metabolism) responded well to the drug.36 37 For these reasons we considered the calcification of the pallidum in this subject to be merely coincidential. In all other cases the CT scan findings were similar to those referred to in the literature. 38 39 The 21 patients make up 9 2% of the 228 cases of Parkinsonism seen at our clinic. In the majority of cases the illness started with tremor and continued its course in a mixed form. Unlike other series6 32 tremor remained an important symptom. In spite of the long course of the disease (19 years on average) only four cases were found to be in an advanced form of disability. Our patient who died was in Hoehn and Yahr stage III. The length of the illness and the good and sustained response to levodopa are in keeping with previous reports.5-7 The incidence of side effects to levodopa has been low (average duration of treatment-5-4 years). In the four patients in an advanced stage intolerance to levodopa was due to severe peak dose dyskinesias. "On-of' and "wearingofW' phenomenon were also observed in these cases. This type of response to levodopa has also been observed by others.6 7 Our series shows significant differences from those hitherto described in terms of familial incidence of Parkinsonism'-3' as well as metabolic disorders found in the patients and their relatives.7 We found Parkinsonism in only two siblings, both of whom demonstrated a similar clinical onset and course. Familial tremor was found in only three cases, all in group 1. Thyroidopathy, diabetes mellitus, or macrocytic anaemia was not found in any of the cases. Arterial hypertension was detected in only four cases. Five patients admitted to having a family history of hypertension and three of diabetes mellitus. There was no thyroid disease in the relatives.
We conclude, from our series, that there is no evidence suggesting that subjects beginning apparent idiopathic Parkinson's disease before the age of 40 have any disorder other than idiopathic Parkinson's disease.
